ONE MAN'S PAIN .... LEADS TO DAVIS INKING DEAL FOR MIGRAINES

          Super Bowl XXXII MVP Terrell Davis has signed a
     multiyear deal with Novartis Pharmaceuticals to be its
     spokesperson and to raise awareness for Migranal, a new
     migraine treatment, according to Adam Schefter of the DENVER
     POST.  Migranal is the same nasal spray Davis used to treat
     his migraine during the Super Bowl.  Davis and Novartis will
     also partner to form the "Terrell Davis Foundation for
     Migraine Education and Treatment" (DENVER POST, 2/5).  
     Davis' deal with Novartis garnered front-page attention in
     the BOSTON GLOBE where Larry Tye reports it is worth
     "several hundred thousand dollars a year."  Davis: "I'm not
     putting my John Hancock on something I'm not truly behind." 
     Part of what made the deal "attractive" to Davis is the
     agreement that each time he scores a touchdown next season,
     he and Novartis will both contribute money to the new
     foundation on migraine research (BOSTON GLOBE, 2/5).